"Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials," appears in the June issue of the Journal of Nuclear Medicine, which is published by SNM. Besides Shankar, co-authors include Daniel Sullivan, Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Md.; John M. Hoffman, Division of Nuclear Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City; Steve Bacharach, Department of Radiology, University of California, San Francisco, Calif.; Michael M. Graham, Division of Nuclear Medicine, Department of Radiology, University of Iowa, Iowa City; Joel Karp, Division of Nuclear Medicine, Department of Radiology, University of Pennsylvania, Philadelphia, Pa.; Adriaan A. Lammertsma, Department of Nuclear Medicine and PET Research, VU University Medical Centre, Amsterdam, the Netherlands; Steven Larson, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, N.Y.; David A. Mankoff, Division of Nuclear Medicine, University of Washington, Seattle; Barry A. Siegel, Mallinckrodt Institute of Radiology, St. Louis, Mo.; and Annick Van den Abbeele and Jeffrey Yap, Department of Radiology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass.
Back to HCB News
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
